Supplements and Featured Publications
Navigating New Data in the Breast Cancer Treatment Paradigm
Clinical Updates in PIK3CA+ Metastatic Breast Cancer
Exploring Tumor Treating Fields Therapy
THIS ARTICLE IS SPONSORED BY NOVOCURE®.
This article includes expert insights from Moshe Giladi, PhD; and Narasimha Kumar Karanam, PhD, BCMAS. Giladi, Novocure’s Chief Science Officer, oversees Novocure’s preclinical research organization and manages external research partnerships and Novocure’s biostatistics and data management teams. Karanam is Novocure’s Medical Science Liaison and has researched the mechanisms of action underlying tumor treating fields therapy.
Recent Advances in the Evolving Treatment Landscape of Melanoma
Bladder Cancer Awareness Month: Spotlighting Key Advances in the Paradigm
Medical World News
Medical World NewsTM Spring 2024 edition features information across the Medical World NewsTM Streaming Network programs, including Behind the ScienceTM, Wellbeing CheckupTM, Deep DiveTM, and more.
2024 EBMT Meeting Reporter
BEST PRACTICES in Managing FGFRi Treatment–Related AEs: Intrahepatic Cholangiocarcinoma
This article is funded by Taiho Oncology, Inc. The publisher is solely responsible for this content. Taiho does not recommend or endorse the use of its products other than as described in the approved labeling. The content of this article is not medical advice, and does not replace independent medical judgment.
Targeting TP53 Mutations in Advanced Solid Tumors
Research Efforts Under Evaluation in Low-Grade Serous Ovarian Cancer
Reviewing Research Efforts Seeking to Raise the Bar in Myelofibrosis
Tracking the Development of Novel Drugs in Glioma
Navigating New Data With Next-Generation BTK Inhibitors in CLL
2023 SOHO Meeting Reporter
Leveraging ctDNA as a Prognostic Biomarker in Breast Cancer
Reviewing Key Updates in the Realm of Breast Cancer
Examining Approaches Under Evaluation in ESR1+ ER+/HER2– Metastatic Breast Cancer
2023 ASH Meeting Reporter: Updates in CLL
2023 ASH Meeting Reporter: Updates in GVHD
Research Efforts Are Underway in the HCC Treatment Paradigm
Updates in Cholangiocarcinoma
This page is funded by Taiho Oncology, Inc. The faculty and publisher are solely responsible for this content. Taiho does not recommend or endorse the use of its products other than as described in the approved labeling. The content of this page is not medical advice and does not replace independent medical judgment.
Recent Updates on TROP2-Directed Antibody-Drug Conjugates in NSCLC
Research Efforts Are Underway in the Prostate Cancer Paradigm
Evaluating Key Clinical Updates in the Realm of Endometrial Cancer
Advances in Precision Medicine in Lung Cancer
Focus on Pathways: Liver Function Assessment in Hepatocellular Carcinoma
Novel Strategies Under Exploration in Pediatric Low-Grade Glioma
Updates on Progress Made in the HCC Treatment Paradigm
Leveraging ctDNA as a Prognostic Biomarker in CRC
